Lemonaid Health

Provider Profile Name: Lemonaid Health
Website: lemonaidhealth.com
Parent Company: Formerly a subsidiary of 23andMe Holding Co. (see Editor’s Note)
Founded: GLP-1 weight loss program launched in August 2024
Provider Type: Telehealth — Virtual Only, Full-Service Platform with Weight Management
Headquarters: San Francisco, CA

Operating Details

• Fully virtual — detailed online intake, licensed provider consultation (video or phone), home delivery
• Cash-pay only — no insurance accepted for membership fees, medication costs, or medical fees
• HSA/FSA eligible
• Not yet available in all 50 states
• No long-term commitment required; transparent pricing that doesn’t change based on dosage amount
• One annual lab test through Quest Diagnostics is included; not available to customers in NY, NJ, RI, or HI
• Compounded semaglutide prepared by a state-licensed, FDA-inspected 503B compounding pharmacy

Approach: Lemonaid Health offers a lean, straightforward approach to GLP-1 care, prescriptions, refills, and quick consults without the layers of coaching or lifestyle tracking other clinics offer. The platform’s model is medication-first: access to the right drug, at a clear price, with no add-on services required. For patients who already have healthy habits and simply need clinical oversight for a GLP-1 prescription, this structure is efficient.

About the Company

Lemonaid Health was acquired by 23andMe in October 2021 for approximately $400 million to integrate Lemonaid’s telehealth capabilities with 23andMe’s genetics platform to offer more personalized care. The GLP-1 weight loss program was announced in August 2024, partly inspired by a 23andMe genetic study exploring why GLP-1 medications work better for some people than others.

Important ownership context: In March 2025, 23andMe filed for Chapter 11 bankruptcy protection amid financial struggles, including a significant data breach in 2023 and declining revenues. Regeneron Pharmaceuticals subsequently announced plans to acquire 23andMe’s DNA testing business and most of its assets for $256 million, but Lemonaid Health was ultimately excluded from that deal. Some Trustpilot reviewers have noted awareness of the bankruptcy situation and expressed uncertainty about the platform’s future, a concern that is worth monitoring before committing to a long-term subscription. Patients should verify Lemonaid Health’s current operating status and ownership directly before enrolling.

What sets Lemonaid Health apart from most platforms in this review series is its breadth of services, beyond weight loss; the platform covers mental health, sexual health, skin care, and primary care, making it a convenient one-stop telehealth solution for patients who want a single platform for multiple health needs.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

GLP-1 Offerings and Weight Loss Services

Lemonaid Health offers compounded semaglutide, Wegovy, Ozempic, Zepbound vials, and metformin, a broader-than-average brand-name and compounded GLP-1 menu.

Compounded Options:

• Compounded Semaglutide (injectable) — weekly injection; standard, 3-month, and 6-month plans; microdosing available
• Compounded Tirzepatide (injectable) — weekly injection; standard, 3-month, and 6-month plans; microdosing available

Brand-Name Options:

• Wegovy (semaglutide, FDA-approved for weight loss) and Ozempic (semaglutide, off-label for weight loss), billed separately from membership
• Zepbound single-dose vials, available as a cash-pay option through LillyDirect, starting at $349/month for 2.5mg; medication delivered, charged, and managed separately from the Lemonaid membership

Non-GLP-1:

• Metformin — indicated for Type 2 diabetes; may be prescribed off-label for weight management at $90 per 3-month supply

No lifestyle coaching, app-based tracking, or nutrition support is included.

Pricing — and What Reviewers Say

Lemonaid Health uses a two-layer pricing model: a $49/month membership fee covers provider access and ongoing support, with medication billed separately on top:

• Membership: $49/month with no long-term commitment required
• Compounded Semaglutide: $299/month (standard) | $249/month (3-month plan) | $229/month (6-month plan); microdosing $199/month
• Compounded Tirzepatide: $299/month (standard) | $249/month (3-month plan) | $229/month (6-month plan); microdosing $199/month
• Ozempic: $1,199/month | Wegovy: $1,599/month
• Zepbound vials (LillyDirect): from $349/month, billed directly by LillyDirect, not Lemonaid

At launch pricing, GLP-1s are currently advertised starting at $129/month; patients should confirm current promotional pricing and whether it applies to their specific plan.

What reviewers say about pricing: Lemonaid Health is consistently praised for pricing transparency, no hidden fees, and no additional charges for dose changes while staying on the same medication. However, patients should be aware that the advertised starting prices are for medication only and do not include the $49/month membership fee, which adds a meaningful cost to the headline rate. The two-layer billing structure, membership plus separately billed medication, can catch new patients off guard.

Reviews from Trustpilot and Google

Lemonaid Health has 189 Trustpilot reviews, a smaller pool than most platforms of comparable scale in this review series, likely reflecting the relatively recent launch of the GLP-1 program in August 2024.

What patients praise:

• Licensed providers described as approachable, knowledgeable, and genuinely engaged in patient care, multiple reviewers single out nurse practitioners and pharmacists by name
• Consistent prescription renewal reminders and upfront pricing transparency were noted positively
• Fast video consultations and same-day prescription processing in many cases

Common complaints:

• Some negative reviews report a decrease in quality following 23andMe’s acquisition, and frustration with auto-delivery billing that continued after cancellation requests
• Medication stock-out situations with no clear resolution pathway, one reviewer reports being told a refund was required, calling customer service after a provider confirmed a stockout
• Reports of overcharging when selecting multi-month plans, with one reviewer noting being billed an extra month despite selecting a 3-month option
• Call center experience described as frustrating, with long phone trees and extended wait times

Compounding Pharmacies Used

Lemonaid Health’s compounded semaglutide is prepared by a state-licensed, FDA-inspected 503B compounding pharmacy that has undergone extensive quality checks. Specific pharmacy names are not publicly disclosed on the platform. The 503B designation is a positive signal; these are FDA-registered outsourcing facilities held to cGMP manufacturing standards, a higher bar than standard 503A compounding pharmacies.

Note: Lemonaid Health’s parent company, 23andMe, filed for Chapter 11 bankruptcy in March 2025. Lemonaid was excluded from Regeneron’s acquisition of 23andMe’s assets, leaving its current ownership and long-term operational continuity uncertain. Patients should confirm the platform’s operating status directly before enrolling in a subscription. The two-layer pricing model ($49/month membership plus separately billed medication) means the total monthly cost is higher than the advertised starting rates. Auto-delivery billing complaints appear in both Trustpilot and BBB records. Read cancellation terms carefully. The GLP-1 program launched in August 2024 and is relatively new, with a limited independent review pool. Compounded medications are not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.